NASS News: Spineology Highlights Duo Lumbar Interbody Fusion System

Spineology Inc., the innovator in anatomy-conserving spine surgery, has announced the initiation of a prospective, post-market lateral interbody fusion study designed to evaluate patient outcomes using its FDA-cleared Duo Lumbar Interbody Fusion System.
 
The Duo System offers a unique implant design that is the first to combine PEEK, titanium, and graft containment mesh elements. The design dramatically reduces the access required to implant a device compared to traditional lateral systems. By minimizing the nerve and soft tissue retraction typically required in these surgeries, the company believes the Duo System can reduce the post-operative thigh pain and other complications commonly associated with the lateral approach. In addition to reducing the exposure required for placement, the Duo implant, once filled, creates a large, load-sharing, endplate-conforming graft pack that expands up to 30mm in width to help maintain spinal correction and support fusion.
 
“We think minimizing the amount of retraction by having the ability to efficiently place a narrow implant and then expanding the implant up to 30mm in width once deployed, offers significant clinical benefits to the patient as well as procedural benefits to the surgeon,” said John Booth, CEO, Spineology Inc. “The Duo System represents next-generation fusion technology and we’re extremely excited to see the clinical results of patients treated in the post-market study,” added Booth.
 
Post-market study sites for the Duo System are in the process of being finalized.
 
The Duo Lumbar Interbody Fusion System will be highlighted at the Spineology booth, #913, at the North American Spine Society (NASS) annual meeting in Orlando, Fla.